48North Cannabis Corp. Announces Sustained Revenue Growth and Reports an Improvement in its Cash Use for Q2 2021

TORONTO, March 1, 2021 /CNW/ – 48North Cannabis Corp. (“48North” or the “Company”) (TSXV: NRTH), a vertically integrated…

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital…

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request

TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV,…

Core One Labs Initiates First Strain Production for Biosynthetic Psilocybin

VANCOUVER, BC / ACCESSWIRE / February 26, 2021 / Core One Labs Inc.(CSE:COOL), (OTC PINK:CLABF), (Frankfurt:LD62, WKN:…

Red Light Holland iMicrodose Pack Receives Authorization for the First Legal Import and Sale of Psilocybin Truffles to Brazil

Toronto, Ontario–(Newsfile Corp. – February 25, 2021) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX)…

PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics Strategy

Toronto, Ontario–(Newsfile Corp. – February 25, 2021) – PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (“PharmaDrug”…

Acreage Announces Sale of Florida Operations To Red White & Bloom Brands

NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.A.U, ACRG.B.U)…

Nova Mentis Autism Clinical Study Approved by Institutional Review Board

VANCOUVER, BC, Feb. 25, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”),…

The Valens Company Reports Financial Results for the Fourth Quarter and Fiscal Year Ended November 30, 2020

Strategic transformation from industry-leading extractor to largest third-party cannabis product manufacturer in Canada driving 292% Q4 2020 provincial…

Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences

Vancouver, British Columbia–(Newsfile Corp. – February 24, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1)…

Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) at the University of Alberta

Partnership Supports Mydecine’s Drug Development & Clinical Trials Pipeline Provides Update on Debt Settlement *NOT FOR DISTRIBUTION…

Core One Labs Finalizes Deal to Acquire Ketamine Infusions Centers of Texas, Entering the US Market for Psychedelic Treatments

VANCOUVER, BC / ACCESSWIRE / February 24, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the “Company”…